Learn More
CD267 (TACI) Polyclonal Antibody, Biotin, PeproTech®, Invitrogen™
Goat Polyclonal Antibody
Brand: Invitrogen 500-P166GBT-1MG
Description
AA Sequence of recombinant protein: SGLGRSRRGG RSRVDQEERF PQGLWTGVAM RSCPEEQYWD PLLGTCMSCK TICNHQSQRT CAAFCRSLSC RKEQGKFYDH LLRDCISCAS ICGQHPKQCA YFCENKLRSP VNLPPELRRQ RSGEVENNSD NSGRYQGLEH RGSEASPALP GLKLSADQV. Preparation: Produced from sera of goats immunized with highly pure Recombinant Human TACI. Anti-Human TACI-specific antibody was purified by affinity chromatography and then biotinylated. Sandwich ELISA: To detect hTACI by sandwich ELISA (using 100 μL/well antibody solution) a concentration of 0.25-1.0 μg/mL of this antibody is required. This biotinylated polyclonal antibody, in conjunction with PeproTech Polyclonal Anti-Human TACI (500-P166G) as a capture antibody, allows the detection of at least 0.2-0.4 ng/well of Recombinant hTACI. Western Blot: To detect hTACI by Western Blot analysis this antibody can be used at a concentration of 0.1-0.2 μg/mL. Used in conjunction with compatible secondary reagents the detection limit for Recombinant hTACI is 1.5-3.0 ng/lane, under either reducing or non-reducing conditions. 500-P166GBT-1MG will be provided as 2 x 500 μg
Members in the TNF superfamily regulate immune responses and induce apoptosis. Two novel members in the TNF family were recently identified and designated BAFF/BLyS/TALL-1/THANK/zTNF4 and April/TALL-2, respectively. BAFF was characterized as a B cell activator since it induced B cell proliferation and immunoglobulin secretion. April regulates immunological and non-immunological cell growth. Three receptors, BCMA, TACI, and BAFF-R, for BAFF and April were recently identified. TACI, like BCMA, binds BAFF and April. TACI and its ligands regulate humoral immune responses, activate NF-kappa-B and c-jun N-terminal kinase, and are involved in B cell associated autoimmune diseases.
Specifications
| CD267 (TACI) | |
| Polyclonal | |
| Biotin | |
| TNFRSF13B | |
| 1200009E08Rik; CD267; CVID; CVID2; IGAD2; NEWGENE_1595998; RYZN; TACI; TNF receptor superfamily member 13B; Tnfrsf13b; TNFRSF14B; transmembrane activator and calcium-modulating and cyclophilin ligand interactor; transmembrane activator and CAML interactor; tumor necrosis factor receptor 13B; tumor necrosis factor receptor superfamily member 13B; tumor necrosis factor receptor superfamily, member 13B | |
| Goat | |
| Antigen affinity chromatography | |
| RUO | |
| 23495 | |
| -20°C |
| ELISA, Western Blot | |
| 0.1-1.0 mg/mL | |
| PBS with no preservative | |
| O14836 | |
| TNFRSF13B | |
| E.coli-derived, 17.8 kDa Recombinant Human TACI | |
| 2 x 500 μg | |
| Primary | |
| Human | |
| Lyophilized |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.